FDA Inspection
Tae Min Kim, M.D., Ph.D.Tae Min Kim, M.D., Ph.D. – FDA Inspection, Dec 15, 2023
Record Details
This FDA Inspection record concerns Tae Min Kim, M.D., Ph.D., with an inspection on December 15, 2023, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · 5b01f199-5510-48c0-b796-1502e9666c59
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1226038
- FDA center
- Human Drugs
- Project area
- Bioresearch Monitoring
- Outcome
- Form 483 issued
Other FDA inspections of Tae Min Kim, M.D., Ph.D.
1| Date | Classification | Office | Project area |
|---|---|---|---|
| August 29, 2025 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
Other documents for Tae Min Kim, M.D., Ph.D.
- FDA Inspection 1283432 - 2025-08-29
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.